J. Biol. Chem., Vol. 265, Issue 29, 17420-17423, Oct, 1990

Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets

P Thiagarajan and JF Tait
Department of Medicine, University of Washington, Seattle 98195.

Proteins of the annexin/lipocortin family act as in vitro anticoagulants by binding to anionic phospholipid vesicles. In this study, we investigated whether annexin V (placental anticoagulant protein I) would bind to human platelets. Annexin V bound to unstimulated platelets in a reversible, calcium-dependent reaction with an apparent Kd of 7 nM and 5000-8000 sites/platelet. Additional binding sites could be induced by several platelet agonists in the following order of effectiveness: A23187 greater than collagen + thrombin greater than collagen greater than thrombin. However, neither ADP nor epinephrine induced additional binding sites. Three other proteins of the annexin family (annexins II, III, and IV) competed for annexin V platelets binding sites with the same relative potencies previously observed for binding to phospholipid vesicles. Phospholipid vesicles containing phosphatidylserine completely inhibited binding of annexin V to platelets. Annexin V completely blocked binding of 125I-factor Xa to thrombin-stimulated platelets. These results support the hypothesis that phosphatidylserine exposure occurs during platelet activation and may be necessary for assembly of the prothrombinase complex on platelet membranes.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				B. Jeppesen, C. Smith, D. F. Gibson, and J. F. Tait Entropic and Enthalpic Contributions to Annexin V-Membrane Binding: A COMPREHENSIVE QUANTITATIVE MODEL J. Biol. Chem., March 7, 2008; 283(10): 6126 - 6135. [Abstract] [Full Text] [PDF]

				F. Rouzet, M. D. Hernandez, F. Hervatin, L. Sarda-Mantel, A. Lefort, X. Duval, L. Louedec, B. Fantin, D. Le Guludec, and J.-B. Michel Technetium 99m-Labeled Annexin V Scintigraphy of Platelet Activation in Vegetations of Experimental Endocarditis Circulation, February 12, 2008; 117(6): 781 - 789. [Abstract] [Full Text] [PDF]

				N. Bogdanova, J. Horst, M. Chlystun, P. J.P. Croucher, A. Nebel, A. Bohring, A. Todorova, S. Schreiber, V. Gerke, M. Krawczak, et al. A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss Hum. Mol. Genet., March 1, 2007; 16(5): 573 - 578. [Abstract] [Full Text] [PDF]

				J. F. Tait, C. Smith, Z. Levashova, B. Patel, F. G. Blankenberg, and J.-L. Vanderheyden Improved Detection of Cell Death In Vivo with Annexin V Radiolabeled by Site-Specific Methods J. Nucl. Med., September 1, 2006; 47(9): 1546 - 1553. [Abstract] [Full Text] [PDF]

				L. Sarda-Mantel, M. Coutard, F. Rouzet, O. Raguin, J.-M. Vrigneaud, F. Hervatin, G. Martet, Z. Touat, P. Merlet, D. Le Guludec, et al. 99mTc-Annexin-V Functional Imaging of Luminal Thrombus Activity in Abdominal Aortic Aneurysms Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2153 - 2159. [Abstract] [Full Text] [PDF]

				Z. Touat, V. Ollivier, J. Dai, M.-G. Huisse, A. Bezeaud, U. Sebbag, T. Palombi, P. Rossignol, O. Meilhac, M.-C. Guillin, et al. Renewal of Mural Thrombus Releases Plasma Markers and Is Involved in Aortic Abdominal Aneurysm Evolution Am. J. Pathol., March 1, 2006; 168(3): 1022 - 1030. [Abstract] [Full Text] [PDF]

				X. Huang, W.-Q. Ding, J. L. Vaught, R. F. Wolf, J. H. Morrissey, R. G. Harrison, and S. E. Lind A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties Blood, February 1, 2006; 107(3): 980 - 986. [Abstract] [Full Text] [PDF]

				I. del Conde, C. N. Shrimpton, P. Thiagarajan, and J. A. Lopez Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation Blood, September 1, 2005; 106(5): 1604 - 1611. [Abstract] [Full Text] [PDF]

				J. F. Tait, C. Smith, and F. G. Blankenberg Structural Requirements for In Vivo Detection of Cell Death with 99mTc-Annexin V J. Nucl. Med., May 1, 2005; 46(5): 807 - 815. [Abstract] [Full Text] [PDF]

				I. del Conde, F. Nabi, R. Tonda, P. Thiagarajan, J. A. Lopez, and N. S. Kleiman Effect of P-Selectin on Phosphatidylserine Exposure and Surface-Dependent Thrombin Generation on Monocytes Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 1065 - 1070. [Abstract] [Full Text] [PDF]

				E. Camors, V. Monceau, and D. Charlemagne Annexins and Ca2+ handling in the heart Cardiovasc Res, March 1, 2005; 65(4): 793 - 802. [Abstract] [Full Text] [PDF]

				T. Takei, Y. Kuge, S. Zhao, M. Sato, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Time Course of Apoptotic Tumor Response After a Single Dose of Chemotherapy: Comparison with 99mTc-Annexin V Uptake and Histologic Findings in an Experimental Model J. Nucl. Med., December 1, 2004; 45(12): 2083 - 2087. [Abstract] [Full Text] [PDF]

				J. R. Davies, J. H. Rudd, and P. L. Weissberg Molecular and Metabolic Imaging of Atherosclerosis J. Nucl. Med., November 1, 2004; 45(11): 1898 - 1907. [Abstract] [Full Text] [PDF]

				Y. Kuge, M. Sato, S. Zhao, T. Takei, K. Nakada, K.-i. Seki, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Feasibility of 99mTc-Annexin V for Repetitive Detection of Apoptotic Tumor Response to Chemotherapy: An Experimental Study Using a Rat Tumor Model J. Nucl. Med., February 1, 2004; 45(2): 309 - 312. [Abstract] [Full Text] [PDF]

				O. Kuge, K. Hasegawa, T. Ohsawa, K. Saito, and M. Nishijima Purification and Characterization of Chinese Hamster Phosphatidylserine Synthase 2 J. Biol. Chem., October 24, 2003; 278(43): 42692 - 42698. [Abstract] [Full Text] [PDF]

				M. Dias-Baruffi, H. Zhu, M. Cho, S. Karmakar, R. P. McEver, and R. D. Cummings Dimeric Galectin-1 Induces Surface Exposure of Phosphatidylserine and Phagocytic Recognition of Leukocytes without Inducing Apoptosis J. Biol. Chem., October 17, 2003; 278(42): 41282 - 41293. [Abstract] [Full Text] [PDF]

				C. Leon, C. Ravanat, M. Freund, J.-P. Cazenave, and C. Gachet Differential Involvement of the P2Y1 and P2Y12 Receptors in Platelet Procoagulant Activity Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1941 - 1947. [Abstract] [Full Text] [PDF]

				J. H. Rand, X.-X. Wu, A. S. Quinn, P. P. Chen, K. R. McCrae, E. G. Bovill, and D. J. Taatjes Human Monoclonal Antiphospholipid Antibodies Disrupt the Annexin A5 Anticoagulant Crystal Shield on Phospholipid Bilayers: Evidence from Atomic Force Microscopy and Functional Assay Am. J. Pathol., September 1, 2003; 163(3): 1193 - 1200. [Abstract] [Full Text] [PDF]

				H. Shankaran, P. Alexandridis, and S. Neelamegham Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension Blood, April 1, 2003; 101(7): 2637 - 2645. [Abstract] [Full Text] [PDF]

				L. Cominacini, A. Fratta Pasini, U. Garbin, A. Pastorino, A. Rigoni, C. Nava, A. Davoli, V. Lo Cascio, and T. Sawamura The platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells J. Am. Coll. Cardiol., February 5, 2003; 41(3): 499 - 507. [Abstract] [Full Text] [PDF]

				T. Mochizuki, Y. Kuge, S. Zhao, E. Tsukamoto, M. Hosokawa, H. W. Strauss, F. G. Blankenberg, J. F. Tait, and N. Tamaki Detection of Apoptotic Tumor Response In Vivo After a Single Dose of Chemotherapy with 99mTc-Annexin V J. Nucl. Med., January 1, 2003; 44(1): 92 - 97. [Abstract] [Full Text] [PDF]

				J. H. Webb, A. M. Blom, and B. Dahlback Vitamin K-Dependent Protein S Localizing Complement Regulator C4b-Binding Protein to the Surface of Apoptotic Cells J. Immunol., September 1, 2002; 169(5): 2580 - 2586. [Abstract] [Full Text] [PDF]

				R. Gonzalez-Conejero, J. Corral, V. Roldan, C. Martinez, F. Marin, J. Rivera, J. A. Iniesta, M. L. Lozano, P. Marco, and V. Vicente A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients Blood, August 28, 2002; 100(6): 2081 - 2086. [Abstract] [Full Text] [PDF]

				K. Kawamoto, J. Aoki, A. Tanaka, A. Itakura, H. Hosono, H. Arai, Y. Kiso, and H. Matsuda Nerve Growth Factor Activates Mast Cells Through the Collaborative Interaction with Lysophosphatidylserine Expressed on the Membrane Surface of Activated Platelets J. Immunol., June 15, 2002; 168(12): 6412 - 6419. [Abstract] [Full Text] [PDF]

				N. Di Simone, R. Castellani, D. Caliandro, and A. Caruso Monoclonal Anti-Annexin V Antibody Inhibits Trophoblast Gonadotropin Secretion and Induces Syncytiotrophoblast Apoptosis Biol Reprod, December 1, 2001; 65(6): 1766 - 1770. [Abstract] [Full Text] [PDF]

				D. Dormann, K. J. Clemetson, and B. E. Kehrel The GPIb thrombin-binding site is essential for thrombin-induced platelet procoagulant activity Blood, October 1, 2000; 96(7): 2469 - 2478. [Abstract] [Full Text] [PDF]

				T. S. Griffith, R. D. Anderson, B. L. Davidson, R. D. Williams, and T. L. Ratliff Adenoviral-Mediated Transfer of the TNF-Related Apoptosis-Inducing Ligand/Apo-2 Ligand Gene Induces Tumor Cell Apoptosis J. Immunol., September 1, 2000; 165(5): 2886 - 2894. [Abstract] [Full Text] [PDF]

				K. Ma, R. Simantov, J.-C. Zhang, R. Silverstein, K. A. Hajjar, and K. R. McCrae High Affinity Binding of beta 2-Glycoprotein I to Human Endothelial Cells Is Mediated by Annexin II J. Biol. Chem., May 12, 2000; 275(20): 15541 - 15548. [Abstract] [Full Text] [PDF]

				S. S. Ahmad, J. M. Scandura, and P. N. Walsh Structural and Functional Characterization of Platelet Receptor-mediated Factor VIII Binding J. Biol. Chem., April 21, 2000; 275(17): 13071 - 13081. [Abstract] [Full Text] [PDF]

				L. A. Harker, L. K. Roskos, U. M. Marzec, R. A. Carter, J. K. Cherry, B. Sundell, E. N. Cheung, D. Terry, and W. Sheridan Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers Blood, April 15, 2000; 95(8): 2514 - 2522. [Abstract] [Full Text] [PDF]

				M. Kakutani, T. Masaki, and T. Sawamura A platelet-endothelium interaction mediated by lectin-like oxidized low-density lipoprotein receptor-1 PNAS, January 4, 2000; 97(1): 360 - 364. [Abstract] [Full Text] [PDF]

				H. Andersen, D. L. Greenberg, K. Fujikawa, W. Xu, D. W. Chung, and E. W. Davie Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity PNAS, September 28, 1999; 96(20): 11189 - 11193. [Abstract] [Full Text] [PDF]

				M. BONOMINI, V. SIROLLI, N. SETTEFRATI, S. DOTTORI, L. DI LIBERATO, and A. ARDUINI Increased Erythrocyte Phosphatidylserine Exposure in Chronic Renal Failure J. Am. Soc. Nephrol., September 1, 1999; 10(9): 1982 - 1990. [Abstract] [Full Text]

				V. T. Heussler, J. Machado Jr, P. C. Fernandez, C. Botteron, C.-G. Chen, M. J. Pearse, and D. A. E. Dobbelaere The intracellular parasite Theileria parva protects infected T cells from apoptosis PNAS, June 22, 1999; 96(13): 7312 - 7317. [Abstract] [Full Text] [PDF]

				C. Gidon-Jeangirard, B. Hugel, V. Holl, F. Toti, J.-L. Laplanche, D. Meyer, and J.-M. Freyssinet Annexin V Delays Apoptosis While Exerting an External Constraint Preventing the Release of CD4+ and PrPc+ Membrane Particles in a Human T Lymphocyte Model J. Immunol., May 15, 1999; 162(10): 5712 - 5718. [Abstract] [Full Text] [PDF]

				Y. Nagai, J. Aoki, T. Sato, K. Amano, Y. Matsuda, H. Arai, and K. Inoue An Alternative Splicing Form of Phosphatidylserine-specific Phospholipase A1 That Exhibits Lysophosphatidylserine-specific Lysophospholipase Activity in Humans J. Biol. Chem., April 16, 1999; 274(16): 11053 - 11059. [Abstract] [Full Text] [PDF]

				J. H. Rand, X.-X. Wu, H. A.M. Andree, J.B. A. Ross, E. Rusinova, M. G. Gascon-Lema, C. Calandri, and P. C. Harpel Antiphospholipid Antibodies Accelerate Plasma Coagulation by Inhibiting Annexin-V Binding to Phospholipids: A "Lupus Procoagulant" Phenomenon Blood, September 1, 1998; 92(5): 1652 - 1660. [Abstract] [Full Text] [PDF]

				L. A. Harker, U. M. Marzec, F. Novembre, I. B. Sundell, E. K. Waller, S. Karpatkin, H. M. McClure, A. B. Kelly, and R. B. Stead Treatment of Thrombocytopenia in Chimpanzees Infected With Human Immunodeficiency Virus by Pegylated Recombinant Human Megakaryocyte Growth and Development Factor Blood, June 15, 1998; 91(12): 4427 - 4433. [Abstract] [Full Text] [PDF]

				N. Zhu, A. Khoshnan, R. Schneider, M. Matsumoto, G. Dennert, C. Ware, and M. M. C. Lai Hepatitis C Virus Core Protein Binds to the Cytoplasmic Domain of Tumor Necrosis Factor (TNF) Receptor 1 and Enhances TNF-Induced Apoptosis J. Virol., May 1, 1998; 72(5): 3691 - 3697. [Abstract] [Full Text] [PDF]

				P. Thiagarajan and C. R. Benedict Inhibition of Arterial Thrombosis by Recombinant Annexin V in a Rabbit Carotid Artery Injury Model Circulation, October 7, 1997; 96(7): 2339 - 2347. [Abstract] [Full Text]

				C. Caulin, G. S. Salvesen, and R. G. Oshima Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell Apoptosis J. Cell Biol., September 22, 1997; 138(6): 1379 - 1394. [Abstract] [Full Text] [PDF]

				P. D. Flynn, C. D. Byrne, T. P. Baglin, P. L. Weissberg, and M. R. Bennett Thrombin Generation by Apoptotic Vascular Smooth Muscle Cells Blood, June 15, 1997; 89(12): 4378 - 4384. [Abstract] [Full Text] [PDF]

				R. F.A. Zwaal and A. J. Schroit Pathophysiologic Implications of Membrane Phospholipid Asymmetry in Blood Cells Blood, February 15, 1997; 89(4): 1121 - 1132. [Full Text] [PDF]

				D. J. Van Antwerp, S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma Suppression of TNF-alpha -Induced Apoptosis by NF-kappa B Science, November 1, 1996; 274(5288): 787 - 789. [Abstract] [Full Text]

				K. A. Hajjar, C. A. Guevara, E. Lev, K. Dowling, and J. Chacko Interaction of the Fibrinolytic Receptor, Annexin II, with the Endothelial Cell Surface. ESSENTIAL ROLE OF ENDONEXIN REPEAT 2 J. Biol. Chem., August 30, 1996; 271(35): 21652 - 21659. [Abstract] [Full Text] [PDF]

				K. Kojima, K. Yamamoto, T. Irimura, T. Osawa, H. Ogawa, and I. Matsumoto Characterization of Carbohydrate-binding Protein p33/41 J. Biol. Chem., March 29, 1996; 271(13): 7679 - 7685. [Abstract] [Full Text] [PDF]

				M.R. Bennett, D.F. Gibson, S.M. Schwartz, and J.F. Tait Binding and Phagocytosis of Apoptotic Vascular Smooth Muscle Cells Is Mediated in Part by Exposure of Phosphatidylserine Circ. Res., December 1, 1995; 77(6): 1136 - 1142. [Abstract] [Full Text]

				J. R. Stratton, T. A. Dewhurst, S. Kasina, J. M. Reno, M. D. Cerqueira, D. G. Baskin, and J. F. Tait Selective Uptake of Radiolabeled Annexin V on Acute Porcine Left Atrial Thrombi Circulation, November 15, 1995; 92(10): 3113 - 3121. [Abstract] [Full Text]

				J. F. Tait, S. Engelhardt, C. Smith, and K. Fujikawa Prourokinase-Annexin V Chimeras J. Biol. Chem., September 15, 1995; 270(37): 21594 - 21599. [Abstract] [Full Text] [PDF]

				C. P.M. Reutelingsperger The Annexins Lupus, August 1, 1994; 3(4): 213 - 216. [PDF]

				A. T. Gentile, T. G. DeLoughery, and J. M. Porter Novel Antithrombotic Agents in Vascular Surgery Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1994; 7(2): 57 - 72. [PDF]

				S. Persad, S. Attwell, V. Gray, M. Delcommenne, A. Troussard, J. Sanghera, and S. Dedhar Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cells PNAS, March 28, 2000; 97(7): 3207 - 3212. [Abstract] [Full Text] [PDF]

				P. A. Merlini, A. Repetto, A. Lombardi, A. Vetrano, R. Fetiveau, C. Cavallini, D. Sappe, A. Salvioni, R. Canziani, S. Savonitto, et al. Effect of Abciximab on Prothrombin Activation and Thrombin Generation in Acute Coronary Syndromes Without ST-Segment Elevation: Global Utilization of Strategies to Open Occluded Coronary Arteries Trial IV in Acute Coronary Syndromes (GUSTO IV ACS) Italian Hematologic Substudy Circulation, February 26, 2002; 105(8): 928 - 932. [Abstract] [Full Text] [PDF]